BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2797879)

  • 1. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
    Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activities of four macrolides: josamycin, erythromycin, spiramycin and roxithromycin, against 424 anaerobic bacteria.
    Derriennic M; Dubreuil L; Reynaud AE; Courtieu AL
    Chemioterapia; 1987 Jun; 6(2 Suppl):159-60. PubMed ID: 3509376
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
    Rolin O; Bouanchaud DH
    Pathol Biol (Paris); 1989 May; 37(5):375-7. PubMed ID: 2780094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro potencies of nine new macrolides.
    Fernandes PB; Hardy DJ
    Drugs Exp Clin Res; 1988; 14(7):445-51. PubMed ID: 3240705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of roxithromycin compared to 5 other macrolides against staphylococci].
    Brun Y; Coulet M; Forey F; Fleurette J
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):613-8. PubMed ID: 3054736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of roxithromycin against hospital bacteria and the concordance curve].
    Soussy CJ; Chanal M; Kitzis MD; Duval J; Cluzel R; Acar JF
    Pathol Biol (Paris); 1988 May; 36(5):420-4. PubMed ID: 2900488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of rokitamycin, a new macrolide antibiotic. Results of a multicenter study].
    Soussy CJ; Le Van Thoi J; Meyran M; Joly B; Derlot E; Morel C
    Pathol Biol (Paris); 1990 May; 38(5):407-12. PubMed ID: 2195450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activities of 14-, 15- and 16-membered macrolides against gram-positive cocci.
    Hamilton-Miller JM
    J Antimicrob Chemother; 1992 Feb; 29(2):141-7. PubMed ID: 1506329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro brodimoprim activity on bacterial strains.
    Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
    J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of A-56268.
    Sefton AM; Maskell JP; Yong FJ; Chi SJ; Williams JD
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):798-802. PubMed ID: 2975218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental research on microbiological profile of josamycin. II: Findings on the phenomenon of resistance in comparison with other macrolides].
    Maury F; Moiraghi Ruggenini A; Grassi R
    G Batteriol Virol Immunol; 1981; 74(7-12):239-49. PubMed ID: 7347696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of roxithromycin against respiratory pathogens.
    Facinelli B; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():33-5. PubMed ID: 12041781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of josamycin against erythromycin-resistant staphylococci as compared to roxythromycin and clarithromycin.
    Guggenbichler JP; Georgopoulos A; Scharrer P; Kobilansky C; Mühlbacher J; Georgopoulos M; Dierich MP
    Infection; 1993; 21(4):259-61. PubMed ID: 8225634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Susceptibility to roxithromycin of gram-positive cocci isolated from patients with lowered immunity].
    Mróz E; Podolak-Dawidziak M; Grzybek-Hryncewicz K; Dworniczek E
    Med Dosw Mikrobiol; 1994; 46(1-2):5-8. PubMed ID: 7967928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).
    Jones RN; Barry AL; Fuchs PC; Thornsberry C
    J Clin Microbiol; 1986 Aug; 24(2):233-9. PubMed ID: 3091634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.